Oxford Brain Diagnostics Ltd
Steven Chance is the Chief Executive Officer & Co-Founder of Oxford Brain Diagnostics Ltd. Prior to this role, Steven served as an Associate Professor in Clinical Neurosciences at the University of Oxford. Additionally, Steven has held positions as a University Research Lecturer at the same institution and as a Director of Studies for Human Sciences at Wadham College. Steven's educational background includes a DPhil in Neuroscience from Queen's College, University of Oxford, and a degree in Entrepreneur (Health Stream) from the Rotman School of Management at the University of Toronto.
Oxford Brain Diagnostics Ltd
Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.